Effects of ifenprodil (2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-l-propanol) on the circulatory and central nervous system were examined in male Sprague-Dawley strain rats treated with ifenprodil 50 and 200 mg/kg/day p.o. for 5 to 30 days. Dose of 200 mg/kg/day slightly inhibited body weight gain for 30 days. Both doses of the drug decreased motor activity and produced a myorelaxation of extremities, ptosis and salivation in a dose-dependent manner; the animals gradually became tolerant to the drug when such was administered repeatedly. Ifenprodil 50 and 200 mg/kg/day consistently lowered systolic blood pressure in conscious rats during the prolonged daily treatment, but reflex tachycardia associated with hypotension tended to decline during the treatment. Neither vasopressor response to noradrenaline nor vasodepressor response to ifenprodil in anesthetized rats after 30 days administration differed as compared with data in control animals. In the aorta isolated from rats treated for 30 days with ifenprodil, the contractile response to noradrenaline was approximately the same as seen with controls, and pA
2 values of ifenprodil against noradrenaline in control and experimental aortas did not differ. Ifenprodil produced hypothermia, and this effect was attenuated during daily treatment with ifenprodil. Ifenprodil decreased contents of noradrenaline in the cerebral cortex, brain stem, heart and aorta, and of dopamine in whole brain during continuous oral treatment for 1 to 30 days, however, serotonin content in whole brain remained unchanged. Ifenprodil 10
-6 ?? 10
-4 M inhibited the uptake of noradrenaline in isolated hypothalamus by 20 ?? 96%, while desmethylimipramine 10
-6 M and phentolamine 10
-4 M inhibited this uptake 76 and 59%, respectively. It may be concluded that hypotensive, a-adrenergic receptor blocking and noradrenaline-depleting actions of ifenproil are not altered during prolonged oral treatment with ifenprodil.
View full abstract